Neup Stock Analysis Neuphoria Therapeutics Gains 7.04 Percent To Hit 4.41 Mark 20260403 1 HSTM Q1 2026 Earnings EPS Surpasses Estimates by Over 21 GIC Q1 2026 Earnings EPS Surpasses Estimates by 266 Stock Rises Modestly VAL Q1 2026 Earnings EPS Misses Estimates as Operational Headwinds Persist AVNW Q1 2026 Earnings Significant EPS Miss Amid Challenging Quarter FNB Q1 2026 Earnings Narrow EPS Miss Offset by Resilient Operations ABXL Q1 2026 Earnings Modest EPS Miss Amid Stable Operations